CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bondy, M. L.
Right arrow Articles by Hsu, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bondy, M. L.
Right arrow Articles by Hsu, T. C.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 2 103-106, Copyright © 1993 by American Association for Cancer Research


ARTICLES

Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients

ML Bondy, MR Spitz, S Halabi, JJ Fueger, SP Schantz, D Sample and TC Hsu
Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

This study evaluated the relationship between family history of cancer and bleomycin-induced mutagen sensitivity. The study included 108 patients who registered at The University of Texas M.D. Anderson Cancer Center from June 1987 to June 1991 with histologically confirmed and previously untreated squamous cell carcinoma of the upper aerodigestive tract. All patients underwent the mutagen sensitivity assay and completed a self-administered risk evaluation questionnaire, including a detailed family history. The patients reported having 650 first-degree relatives, including 54 cases with cancers. The patients were classified as mutagen sensitive (> or = 1 chromosome break/cell) or not mutagen sensitive (< or = 0.99 chromosome breaks/cell). Odds ratios (ORs) were calculated to test for significant associations between mutagen sensitivity and family history of cancer. We found a significant OR (OR = 2.63; 95% confidence interval = 1.06-6.53) for patients who were mutagen sensitive and had one first-degree relative affected with cancer. For mutagen-sensitive patients with two or more first-degree relatives affected with cancer, the OR increased to 6.59 (95% confidence interval = 1.69-25.72). Although 88% of the patients were ever smokers, cigarette smoking was not found to be related to mutagen sensitivity. The study findings suggest that patients who have defective DNA repair capability as evidenced by the mutagen sensitivity assay are significantly more likely to report a family history of cancer than patients who are not mutagen sensitive. Further studies are needed to confirm that mutagen-sensitive individuals have inherited an increased risk of cancer.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Spitz, Q. Wei, Q. Dong, C. I. Amos, and X. Wu
Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 689 - 698.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
S. P. Schantz, Q. Huang, K. Shah, V.V.V.S. Murty, T.C. Hsu, G. Yu, P. E. Andersen, A. G. Huvos, and R. S.K. Chaganti
Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers
Carcinogenesis, June 1, 2000; 21(6): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. M. Sturgis, E. J. Castillo, L. Li, R. Zheng, S. A. Eicher, G. L. Clayman, S. S. Strom, M. R. Spitz, and Q. Wei
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck
Carcinogenesis, November 1, 1999; 20(11): 2125 - 2129.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Cloos, E. J. C. Nieuwenhuis, D. I. Boomsma, D. J. Kuik, M. L. T. van der Sterre, F. Arwert, G. B. Snow, and B. J. M. Braakhuis
Inherited Susceptibility to Bleomycin-Induced Chromatid Breaks in Cultured Peripheral Blood Lymphocytes
J Natl Cancer Inst, July 7, 1999; 91(13): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
J. Cloos, C. B.A. Reid, M. L.T. van der Sterre, H. Tobi, C. R. Leemans, G. B. Snow, and B. J.M. Braakhuis
A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects
Mutagenesis, January 1, 1999; 14(1): 87 - 93.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
N. Shimizu, N. Itoh, H. Utiyama, and G. M. Wahl
Selective Entrapment of Extrachromosomally Amplified DNA by Nuclear Budding and Micronucleation during S Phase
J. Cell Biol., March 23, 1998; 140(6): 1307 - 1320.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
W. D Foulkes, J.-S. Brunet, W. Sieh, M. J Black, G. Shenouda, and S. A Narod
Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study
BMJ, September 21, 1996; 313(7059): 716 - 721.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1993 by the American Association for Cancer Research.